Thérapie de combinaison d'inhibitors de fusion/entrée du VIH ciblant gp41

• 收藏
• 分享

专利权人:

New York Blood Center

发明人:

申请号：

EP11167541.9

公开号：

EP2377880A3

申请日:

2009.08.12

申请国别(地区):

EP

年份:

2012

代理人:

摘要：

A pharmaceutical composition for the prophylactic and therapeutic treatment of human immunodeficiency (HIV) infection comprising combinations of HIV fusion/entry inhibitors with different target sites in HIV gp41 or different mechanisms of action. A kit comprising two or more HIV fusion/entry inhibitors with different target sites in HIV gp41 or different mechanisms of action is also provided.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/